Name: SVA Balance Sheet - Sinovac Biotech Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

SVA - Sinovac Biotech Ltd.

USD | NASDAQ | Healthcare

SVA Balance Sheet - Sinovac Biotech Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008
Cash And Short Term Investments
Cash And Equivalents	488.2	335.3	1,124.0	3,878.7	11,608.9	1,041.0	152.7	158.2	114.4	62.4	63.8	89.8	106.5	91.2	104.3	101.6	75.0	32.9
Restricted Cash	668.2	266.9	5.2	8.3	10.9	9.2	3.2	0.0	1.5	3.0	1.6	0.0	-	-	-	-	-	-
Short Term Investments	5,483.1	9,613.3	9,894.6	6,653.7	1,806.4	135.2	50.3	18.9	-	-	-	-	-	-	-	1.5	-
Cash And Short Term Investments	5,971.3	9,948.6	11,018.5	10,532.3	13,415.3	1,176.3	203.0	177.1	114.4	62.4	63.8	89.8	106.5	91.2	104.3
Receivables
Accounts Receivable	286.3	300.9	424.9	486.6	942.7	253.5	113.7	74.5	66.2	49.8	39.0	40.7	31.9	23.4	17.8
Current Assets
Inventory	94.3	96.9	135.6	175.3	391.1	105.8	27.8	25.1	19.6	14.1	18.7	18.7	14.3	10.5	8.1	14.5
Non-Current Assets
Property, Plant & Equipment Gross	1,565.8	1,487.2	1,471.8	1,254.8	995.5	257.9	125.7	119.5	122.5	105.3	100.9	98.5	95.4	89.2
Current Liabilities
Accounts Payable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	494.9	375.8	253.9	11.8	15.8	35.1	5.9	7.2	33.0	40.7	-	-	-	-	-	-
Common Equity
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Supplementary Data
Total Debt	494.9	375.8	253.9	11.8	15.8	35.1	5.9	10.5	51.2	72.0	21.8	47.4	16.2	3.3	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q4 FY 25	Q4 FY 24	Q4 FY 23	Q4 FY 22	Q4 FY 21	Q4 FY 20	Q4 FY 19	Q4 FY 18	Q4 FY 17	Q4 FY 16	Q4 FY 15	Q4 FY 14	Q4 FY 13	Q4 FY 12	Q4 FY 11	Q4 FY 10	Q4 FY 09	Q4 FY 08
Cash And Short Term Investments
Cash And Equivalents	488.2	335.3	1,124.0	3,878.7	11,608.9	1,041.0	152.7	158.2	114.4	62.4	63.8	89.8	106.5	91.2	104.3	101.6	75.0
Restricted Cash	668.2	266.9	5.2	8.3	10.9	9.2	3.2	0.0	1.5	3.0	1.6	0.0	-	-	-	-	-	-
Short Term Investments	5,483.1	9,613.3	9,894.6	6,653.7	1,806.4	135.2	50.3	18.9	-	-	-	-	-	-	-	1.5	-
Cash And Short Term Investments	5,971.3	9,948.6	11,018.5	10,532.3	13,415.3	1,176.3	203.0	177.1	114.4	62.4	63.8	89.8	106.5	91.2	104.3
Receivables
Accounts Receivable	286.3	300.9	424.9	486.6	942.7	253.5	113.7	74.5	66.2	49.8	39.0	40.7	31.9	23.4	17.8
Current Assets
Inventory	94.3	96.9	135.6	175.3	391.1	105.8	27.8	25.1	19.6	14.1	18.7	18.7	14.3	10.5	8.1	14.5
Non-Current Assets
Property, Plant & Equipment Gross	1,565.8	1,487.2	1,471.8	1,254.8	995.5	257.9	125.7	119.5	122.5	105.3	100.9	98.5	95.4	89.2
Current Liabilities
Accounts Payable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	494.9	375.8	253.9	11.8	15.8	35.1	5.9	7.2	33.0	40.7	-	-	-	-	-	-
Common Equity
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Supplementary Data
Total Debt	494.9	375.8	253.9	11.8	15.8	35.1	5.9	10.5	51.2	72.0	21.8	47.4	16.2	3.3	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)